The FDA accepted the NDA for AXS-12 (reboxetine) for the treatment of cataplexy in narcolepsy, setting a PDUFA target action date of May 1, 2027.

In response to a rising multistate outbreak of Cyclospora infections, the CDC has issued a health advisory for clinicians.

Higher levels of daytime light exposure are associated with a lower risk for dementia, while no association was seen for nighttime light.

Compared with the general population, National Football League athletes have higher neurodegenerative mortality.

Significant productivity loss can be seen up to 15 years before early-onset dementia diagnosis, potentially explained by delays in diagnosis.

Counties across the US with limited access to radiation oncology practice sites tend to be rural and have higher levels of poverty.